Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Versleijen AAM"" wg kryterium: Autor


Wyświetlanie 1-4 z 4
Tytuł:
Correction to: Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer's disease, but not in cerebral amyloid angiopathy.
Autorzy:
De Kort AM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, 6500, HB, Nijmegen, The Netherlands.
Kuiperij HB; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, 6500, HB, Nijmegen, The Netherlands.
Alcolea D; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
Kersten I; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, 6500, HB, Nijmegen, The Netherlands.
Versleijen AAM; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Greenberg SM; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Stoops E; ADx NeuroSciences, Ghent, Belgium.
Schreuder FHBM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, 6500, HB, Nijmegen, The Netherlands.
Klijn CJM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, 6500, HB, Nijmegen, The Netherlands.
Lleó A; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
Claassen JAHR; Department of Geriatrics, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, Nijmegen, The Netherlands.
Verbeek MM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, 6500, HB, Nijmegen, The Netherlands. .; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands. .
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2021 Nov 16; Vol. 13 (1), pp. 189. Date of Electronic Publication: 2021 Nov 16.
Typ publikacji:
Published Erratum
Tytuł:
Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer's disease, but not in cerebral amyloid angiopathy.
Autorzy:
De Kort AM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Kuiperij HB; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Alcolea D; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
Kersten I; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Versleijen AAM; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Greenberg SM; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Stoops E; ADx NeuroSciences, Ghent, Belgium.
Schreuder FHBM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Klijn CJM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Lleó A; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
Claassen JAHR; Department of Geriatrics, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, Nijmegen, The Netherlands.
Verbeek MM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands. .; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands. .
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2021 Sep 24; Vol. 13 (1), pp. 160. Date of Electronic Publication: 2021 Sep 24.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Alzheimer Disease*/complications
Cerebral Amyloid Angiopathy*/complications
Amyloid beta-Peptides ; Biomarkers ; Glucose-6-Phosphate Isomerase ; Humans ; Nerve Growth Factors ; Protein Serine-Threonine Kinases
Czasopismo naukowe
Tytuł:
Apolipoprotein D: a potential biomarker for cerebral amyloid angiopathy.
Autorzy:
Kuiperij HB; Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Hondius DC; Department of Pathology, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.; Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Neuroscience Campus Amsterdam, VU University, Amsterdam, The Netherlands.
Kersten I; Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Versleijen AAM; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Rozemuller AJM; Department of Pathology, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
Greenberg SM; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Schreuder FHBM; Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, Radboud University Medical Center, Nijmegen, The Netherlands.
Klijn CJM; Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, Radboud University Medical Center, Nijmegen, The Netherlands.
Verbeek MM; Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Pokaż więcej
Źródło:
Neuropathology and applied neurobiology [Neuropathol Appl Neurobiol] 2020 Aug; Vol. 46 (5), pp. 431-440. Date of Electronic Publication: 2020 Feb 03.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Apolipoproteins D/*metabolism
Biomarkers/*cerebrospinal fluid
Cerebral Amyloid Angiopathy/*pathology
Aged ; Cerebral Amyloid Angiopathy/metabolism ; Female ; Humans ; Male ; Middle Aged
Czasopismo naukowe
    Wyświetlanie 1-4 z 4

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies